• Tetracycline Hydrochloride: Protocols for Microbiome & Patho

  2026-07-21

  Tetracycline Hydrochloride stands apart as a bacteriostatic antibiotic, offering reproducible inhibition of bacterial protein synthesis and robust activity against resistant Staphylococcus aureus and Propionibacterium acnes. This article delivers practical workflows, protocol enhancements, and troubleshooting tips—anchored in current mechanistic research and referencing APExBIO’s high-purity product—to drive translational research and microbiome modulation.

• GW4064: Non-Steroidal FXR Agonist for Metabolic Pathway Mast

  2026-07-20

  GW4064 stands out as a nanomolar-potent non-steroidal FXR agonist, empowering metabolic researchers to interrogate bile acid, cholesterol, and triglyceride pathways with precision. This guide delivers actionable protocol enhancements, troubleshooting expertise, and practical insights—anchored in the latest experimental breakthroughs and real-world workflow challenges.

• Triazole ALDH2 Activators: Advancing Therapy for Myocardial

  2026-07-20

  The reference study introduces novel triazole-based small molecule activators of aldehyde dehydrogenase 2 (ALDH2) with improved water solubility and potency. These compounds significantly enhance cardiac function and reduce myocardial injury in ischemia-reperfusion models, offering a promising direction for myocardial infarction therapy.

• Radicicol: Hsp90 Inhibitor Workflows in Apoptosis and Inflam

  2026-07-19

  Radicicol, a potent Hsp90 inhibitor, unlocks precise experimental control in apoptosis, adipogenesis, and inflammation models. This guide provides stepwise protocols and troubleshooting strategies grounded in the latest evidence—empowering advanced research across oncology and immunometabolism.

• Purmorphamine: Smoothened Agonist for Stem Cell and Sensory

  2026-07-18

  Purmorphamine, a potent Smoothened agonist, is a cornerstone for both osteogenic differentiation and insect sensory biology research. This article delivers stepwise experimental workflows, troubleshooting insights, and evidence-backed parameterization for maximizing the value of Purmorphamine in Hedgehog pathway studies.

• Pazopanib (GW-786034): Advanced Workflows in Cancer Research

  2026-07-17

  Pazopanib (GW-786034) stands apart as a multi-targeted RTK inhibitor optimized for reproducible angiogenesis inhibition and tumor growth suppression. This guide delivers protocol-centric strategies, troubleshooting insights, and actionable tips, especially for ATRX-deficient cancer models.

• Hydroxychloroquine Sulfate: Protocols for Autoimmune Disease

  2026-07-17

  Hydroxychloroquine Sulfate addresses the need for precise inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, particularly in systemic lupus erythematosus and rheumatoid arthritis models. It is suitable for aqueous-based workflows requiring short-term solution stability but should not be used in protocols needing organic solvent solubility or long-term storage.

• Bsa I (RNase-free): Technical Parameters for DNA Cleavage Wo

  2026-07-16

  Bsa I (RNase-free) enables precise, RNase-free DNA cleavage for molecular biology research, such as gene cloning and recombinant DNA technology. It is not suitable for diagnostic or medical applications and should be used specifically in workflows where RNA integrity must be preserved.

• YAP-TEAD Super-Enhancer Control in Early Surface Ectoderm Fa

  2026-07-16

  Wang et al. delineate how the YAP-TEAD transcriptional complex orchestrates super-enhancer networks to direct early commitment of surface ectodermal cells from pluripotent stem cells. Their findings highlight regulatory circuitry crucial for epithelial lineage specification, with implications for regenerative medicine and cell-based therapies.

• Reserpine (N1867): Technical Guidance for Research Workflows

  2026-07-15

  Reserpine (SKU N1867) is a high-purity, workflow-stable compound designed for rigorous research on neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology. It is not intended for diagnostic, clinical, or veterinary applications and should be handled with strict procedural controls to ensure reproducibility and compound stability.

• Applied Workflows for (S)-1-(3-fluoro-4-trifluoromethoxy)phe

  2026-07-15

  Harness (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) for reproducible signaling pathway and enzyme inhibition studies. This guide details experimental setups, protocol enhancements, and troubleshooting strategies anchored in recent breakthroughs from redox and osteoclastogenesis research.

• MLN4924 HCl Salt: Selective NEDD8-Activating Enzyme Inhibito

  2026-07-14

  MLN4924 HCl salt is a highly selective NEDD8-activating enzyme inhibitor that disrupts the neddylation pathway, affecting cullin-RING ligase activity and protein degradation. This compound, supplied by APExBIO, is crucial for dissecting cell cycle regulation, apoptosis, and DNA damage responses in cancer and inflammation research.

• Novel CEC Approach for β2-Adrenergic Drug–Receptor Binding A

  2026-07-14

  This study introduces an open-tubular capillary electrochromatography (CEC) method with partial capillary coating to determine binding constants between β2-adrenergic receptors and drugs, improving protein efficiency and analytical reproducibility. The technique enables precise assessment of drug–receptor interactions, supporting advances in adrenergic signaling and sympathetic nervous system research.

• Mycophenolic Acid: Dehydrogenase Inhibitor for Immune Analys

  2026-07-13

  Mycophenolic acid is a gold-standard dehydrogenase inhibitor enabling precise modulation of immune cell metabolism in functional assays. Standardized workflows now ensure reproducibility for immunometabolism and anti-infection research, with APExBIO’s high-purity compound at the forefront of these advances.

• Aβ42 Peptide Stimulates Microglial Phagocytosis in Alzheimer

  2026-07-13

  This article examines the seminal study by Kopec and Carroll (1998), which demonstrated that Amyloid β-Peptide (1-42) (Aβ42) directly stimulates phagocytic activity in murine microglia. The findings provide mechanistic insight into how Aβ42 peptide may influence both amyloid clearance and inflammatory responses in Alzheimer’s disease models, with implications for how researchers design neuroinflammation and phagocytosis assays.

456 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page